Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Related Citations for PubMed (Select 23555099)

1.

Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.

Youngwon N, Kim JE, Lim HS, Han KS, Kim HK.

Biomed Res Int. 2013;2013:856754. doi: 10.1155/2013/856754. Epub 2013 Feb 21.

2.
3.

Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.

Machlus KR, Colby EA, Wu JR, Koch GG, Key NS, Wolberg AS.

Thromb Haemost. 2009 Nov;102(5):936-44. doi: 10.1160/TH09-03-0180.

4.

Coagulation factors and the protein C system as determinants of thrombin generation in a normal population.

Dielis AW, Castoldi E, Spronk HM, van Oerle R, Hamulyák K, Ten Cate H, Rosing J.

J Thromb Haemost. 2008 Jan;6(1):125-31. Epub 2007 Nov 6.

PMID:
17988231
5.

Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults.

Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S.

Am J Clin Pathol. 2013 Mar;139(3):370-9. doi: 10.1309/AJCPC5C4AGFRDKMX.

6.

Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method.

Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell'Era A, Iannuzzi F, Aghemo A, Mannucci PM.

Hepatology. 2010 Jul;52(1):249-55. doi: 10.1002/hep.23653.

PMID:
20578143
7.

Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.

Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P.

Hepatology. 2005 Mar;41(3):553-8.

PMID:
15726661
8.

Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.

Tripodi A, Primignani M, Lemma L, Chantarangkul V, Mannucci PM.

J Hepatol. 2013 Aug;59(2):265-70. doi: 10.1016/j.jhep.2013.03.036. Epub 2013 Apr 11.

PMID:
23583273
9.

Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis.

Delahousse B, Labat-Debelleix V, Decalonne L, d'Alteroche L, Perarnau JM, Gruel Y.

Thromb Haemost. 2010 Oct;104(4):741-9. doi: 10.1160/TH10-01-0040. Epub 2010 Aug 30.

PMID:
20806106
10.

Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.

Chaireti R, Rajani R, Bergquist A, Melin T, Friis-Liby IL, Kapraali M, Kechagias S, Lindahl TL, Almer S.

Thromb Res. 2014 Aug;134(2):455-61. doi: 10.1016/j.thromres.2014.05.012. Epub 2014 May 13.

PMID:
24913997
11.

An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.

Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM.

Gastroenterology. 2009 Dec;137(6):2105-11. doi: 10.1053/j.gastro.2009.08.045. Epub 2009 Aug 23.

PMID:
19706293
12.

Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.

Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, Porte RJ.

J Hepatol. 2010 Mar;52(3):355-61. doi: 10.1016/j.jhep.2009.12.001. Epub 2009 Dec 24.

PMID:
20132999
13.

Thrombin generation in paediatric patients with congenital heart disease. Determination by calibrated automated thrombography.

Koestenberger M, Cvirn G, Rosenkranz A, Leschnik B, Raith W, Muntean W.

Hamostaseologie. 2008 Oct;28 Suppl 1:S61-6.

PMID:
18958342
14.

Determinants of the APTT- and ETP-based APC sensitivity tests.

de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM.

J Thromb Haemost. 2005 Jul;3(7):1488-94.

PMID:
15978106
15.

Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis.

Jeong JC, Kim JE, Ryu JW, Joo KW, Kim HK.

Thromb Res. 2013 Nov;132(5):604-9. doi: 10.1016/j.thromres.2013.09.002. Epub 2013 Sep 6.

PMID:
24060191
16.

Thrombin generation determined by calibrated automated thrombography (CAT) in pediatric patients with congenital heart disease.

Koestenberger M, Cvirn G, Nagel B, Rosenkranz A, Leschnik B, Gamillscheg A, Beitzke A, Muntean W.

Thromb Res. 2008;122(1):13-9. Epub 2007 Oct 3.

PMID:
17915295
17.

Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma.

Tripodi A, Chantarangkul V, Primignani M, Clerici M, Dell'era A, Aghemo A, Mannucci PM.

Intern Emerg Med. 2012 Apr;7(2):139-44. doi: 10.1007/s11739-011-0528-4. Epub 2011 Feb 5.

PMID:
21298360
18.

Prominent protein Z-induced thrombin inhibition in cirrhosis: A new functional assay for hypercoagulability assessment.

Kim SY, Kim JE, Kim YJ, Han KS, Kim HK.

J Gastroenterol Hepatol. 2015 Apr;30(4):784-93. doi: 10.1111/jgh.12800.

PMID:
25303721
19.

Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.

Tripodi A, Chantarangkul V, Mannucci PM.

Br J Haematol. 2009 Oct;147(1):77-82. doi: 10.1111/j.1365-2141.2009.07833.x. Epub 2009 Jul 30.

PMID:
19659548
20.

High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications.

Kim HK, Kim JE, Park SH, Kim YI, Nam-Goong IS, Kim ES.

J Diabetes Complications. 2014 May-Jun;28(3):365-9. doi: 10.1016/j.jdiacomp.2014.01.006. Epub 2014 Jan 17.

PMID:
24560421
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk